GO:0006925 inflammatory cell apoptotic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006925 describes the apoptotic process occurring in inflammatory cells such as neutrophils and macrophages, a key resolution mechanism in inflammation.
• Apoptotic inflammatory cells release metabolites that act as tissue messengers, influencing surrounding cells and immune responses.
• Efferocytosis, the clearance of apoptotic inflammatory cells, is essential for resolving inflammation and preventing autoimmunity.
• Dysregulated inflammatory cell apoptosis contributes to diseases including inflammatory arthritis, cancer, and chronic infections.
• Key genes orchestrating this process include CASP3, CASP8, BAX, BCL2, and TP53, which are common targets for CRISPR-based functional studies.
• CRISPR knockout, knock-in, and overexpression models enable precise dissection of apoptotic pathways in inflammatory cells for drug discovery.
Description
Inflammatory cell apoptotic process (GO:0006925) is defined as any apoptotic process in an inflammatory cell, such as a neutrophil or macrophage, that participates in the inflammatory response to foreign substances. Apoptosis of these cells is not merely a passive death but an actively regulated program that determines the duration and intensity of inflammation. The timely removal of apoptotic inflammatory cells by phagocytes, a process called efferocytosis, is critical for tissue homeostasis and resolution of inflammation. Defects in this process can lead to persistent inflammation, autoimmunity, and tissue damage. Researchers study GO:0006925 to understand how inflammatory cells die and how their clearance influences disease outcomes, from arthritis to cancer. This article synthesizes current knowledge on the mechanisms, key genes, and experimental models used to investigate inflammatory cell apoptosis, providing a resource for biomedical researchers.
inflammatory cell apoptotic process At A Glance
| GO ID | GO:0006925 |
|---|---|
| GO term | inflammatory cell apoptotic process |
| Ontology | biological_process |
| Synonym | apoptosis of inflammatory cells; inflammatory cell apoptosis; programmed cell death of inflammatory cells by apoptosis |
| Major function | Regulated cell death of inflammatory cells (e.g., neutrophils, macrophages) during inflammation |
| Related process | Efferocytosis, resolution of inflammation, immune homeostasis |
| Key cell types | Neutrophils, macrophages, dendritic cells, mast cells |
| Disease relevance | Inflammatory arthritis, cancer, chronic infections, autoimmunity |
What Is GO:0006925?
GO:0006925, inflammatory cell apoptotic process, refers to the programmed cell death by apoptosis that occurs in inflammatory cells, which are any cells participating in the inflammatory response to a foreign substance, such as neutrophils and macrophages. This process is a biological process that encompasses the molecular events leading to apoptotic cell death in these specific cell types, distinguishing it from apoptosis in other cell contexts. It is synonymous with terms like apoptosis of inflammatory cells and programmed cell death of inflammatory cells by apoptosis.
Why Is inflammatory cell apoptotic process Important in Cell Biology?
Understanding inflammatory cell apoptotic process is crucial because it governs the resolution of inflammation and prevents chronic inflammatory diseases. Apoptotic inflammatory cells release metabolites that act as tissue messengers, influencing immune cell recruitment and function. Impaired clearance of apoptotic cells can lead to secondary necrosis, autoantigen exposure, and autoimmune responses. Moreover, manipulating this process has therapeutic potential in conditions such as inflammatory arthritis, where defective apoptosis contributes to persistent inflammation. In cancer, resistance to apoptosis in inflammatory cells can promote tumor progression. Thus, GO:0006925 is a central node in inflammation biology with broad clinical implications.
• Controls the lifespan of neutrophils and macrophages, limiting tissue damage during inflammation.
• Essential for resolution of inflammation through efferocytosis by macrophages.
• Dysregulation linked to chronic inflammatory diseases such as rheumatoid arthritis.
• Apoptotic cell-derived metabolites act as signals that modulate tissue repair and immune responses.
• Plays a role in cancer immunosurveillance and tumor-promoting inflammation.
• Target for anti-inflammatory therapies aimed at promoting apoptosis of pathogenic inflammatory cells.
• Involved in host defense against pathogens by regulating neutrophil turnover.
• Provides a mechanism for preventing autoimmunity by silent clearance of dying cells.
What Happens During inflammatory cell apoptotic process?
Initiation of Apoptosis in Inflammatory Cells
In simple terms: Inflammatory cells receive signals to die, which can come from within or outside the cell.
Apoptosis in inflammatory cells can be triggered by intrinsic stressors such as DNA damage or extrinsic signals like death receptor activation. In neutrophils, constitutive apoptosis occurs rapidly, but inflammatory mediators can delay it, prolonging their presence at sites of inflammation. The balance between pro-survival and pro-apoptotic signals determines the fate of these cells.
Mitochondrial Outer Membrane Permeabilization
In simple terms: The mitochondria, the cell's power plants, become leaky, releasing factors that drive cell death.
The intrinsic apoptotic pathway involves mitochondrial outer membrane permeabilization (MOMP), regulated by BCL-2 family proteins such as BAX and BAK. This leads to cytochrome c release and apoptosome formation, activating caspase-9 and downstream executioner caspases. In inflammatory cells, this pathway is modulated by inflammatory cues to control cell lifespan.
Caspase Activation and Execution
In simple terms: A cascade of enzymes called caspases dismantles the cell in an orderly way.
Executioner caspases, particularly caspase-3 and caspase-7, cleave key cellular substrates, leading to characteristic apoptotic morphology. Caspase-3 expression can be suppressed by inflammation-induced occludin downregulation in epithelial cells, highlighting cross-talk between inflammatory signaling and apoptosis machinery. In inflammatory cells, caspase activation is tightly regulated to avoid premature death.
Formation of Apoptotic Bodies and Release of Metabolites
In simple terms: The dying cell breaks into small packages that send signals to other cells.
Apoptotic cells package their contents into apoptotic bodies, which can act as messengers. Metabolites released from apoptotic cells, such as ATP and UTP, influence tissue microenvironments and immune cell behavior. These signals can promote efferocytosis and tissue repair.
Efferocytosis and Resolution of Inflammation
In simple terms: Cleanup cells eat the dying inflammatory cells, which helps stop inflammation.
Efferocytosis is the phagocytic clearance of apoptotic cells by macrophages and other phagocytes. This process is critical for resolving inflammation and preventing secondary necrosis. Efferocytosis-fueled macrophage metabolism supports the resolution program, including secretion of anti-inflammatory mediators. Defective efferocytosis is linked to inflammatory arthritis and autoimmunity.
Key Genes Involved in GO:0006925 inflammatory cell apoptotic process
The following genes and proteins are central to the regulation and execution of inflammatory cell apoptotic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP3 | Executioner caspase; cleaves substrates during apoptosis | Knockout models to study apoptosis resistance |
| CASP8 | Initiator caspase in extrinsic apoptosis | Point mutations to dissect death receptor signaling |
| CASP9 | Initiator caspase in intrinsic apoptosis | Knockout to assess mitochondrial pathway |
| BAX | Pro-apoptotic BCL-2 family member; MOMP | Overexpression and KO models |
| BCL2 | Anti-apoptotic; inhibits MOMP | Overexpression to delay apoptosis |
| TP53 | Tumor suppressor; induces apoptosis upon stress | Knockout to study DNA damage response |
| MCL1 | Anti-apoptotic BCL-2 family member | Knockout to sensitize cells to apoptosis |
| BID | BH3-only protein; links extrinsic and intrinsic pathways | Point mutation to study crosstalk |
| CYCS | Cytochrome c; released from mitochondria | Tagged knock-in for imaging |
| APAF1 | Apoptosome component; activates caspase-9 | Knockout to block intrinsic apoptosis |
| XIAP | Inhibitor of apoptosis proteins; inhibits caspases | Overexpression to block apoptosis |
| OCLN | Occludin; downregulation limits epithelial apoptosis by suppressing caspase-3 | Knockout to study inflammation-induced apoptosis |
| GSDMD | Gasdermin D; mediates pyroptosis, crosstalk with apoptosis | Knockout to separate apoptosis from pyroptosis |
| P2RX7 | Purigenic receptor; senses ATP from apoptotic cells | Knockout to study metabolite signaling |
| AXL | Receptor tyrosine kinase; recognizes apoptotic cells for efferocytosis | Knockout to study clearance |
| MERTK | Phagocytic receptor for apoptotic cells | Knockout to study efferocytosis |
| ITGB3 | Integrin; involved in phagocytosis of apoptotic cells | Knockout to study adhesion |
| MFGE8 | Bridging molecule between apoptotic cells and phagocytes | Overexpression to enhance efferocytosis |
How Is inflammatory cell apoptotic process Regulated?
Inflammatory cell apoptotic process is regulated at multiple levels. Efferocytosis itself is a regulated process that can be modulated by metabolites released from apoptotic cells, which act as tissue messengers. Macrophage metabolism fueled by efferocytosis influences the resolution of inflammation, with pathways such as glycolysis and oxidative phosphorylation playing roles. Inflammatory mediators can delay neutrophil apoptosis, prolonging inflammation. Conversely, pro-resolving mediators promote apoptosis and clearance. The process is also regulated by BCL-2 family proteins and caspases, which are subject to post-translational modifications and transcriptional control. Understanding these regulatory layers is essential for therapeutic targeting.
inflammatory cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MERTK | Inflammatory arthritis; defective efferocytosis | Knockout mouse or human macrophage KO |
| CASP3 | Cancer; apoptosis resistance | Point mutation to disable catalytic activity |
| OCLN | Chronic infections; epithelial apoptosis regulation | Knockout in epithelial cells |
| AXL | Autoimmunity; impaired clearance | Overexpression to enhance efferocytosis |
| P2RX7 | Inflammation; metabolite sensing | Knockout to block ATP signaling |
Inflammatory Arthritis
In inflammatory arthritis, defective clearance of apoptotic inflammatory cells contributes to persistent inflammation and joint damage. Efferocytosis components are often impaired, leading to accumulation of secondary necrotic cells and autoantigen release. Targeting apoptotic cell clearance pathways may offer therapeutic benefits.
Cancer
Apoptosis resistance in inflammatory cells can promote tumor progression by sustaining a pro-inflammatory microenvironment. Conversely, inducing apoptosis in tumor-associated macrophages may enhance anti-tumor immunity. Apoptotic body-derived signals can also influence cancer cell behavior.
Chronic Infections
Pathogens can modulate inflammatory cell apoptosis to evade host defense. For example, inflammation-induced occludin downregulation limits epithelial apoptosis, which may affect pathogen clearance. Dysregulated apoptosis can lead to tissue damage or persistence of infection.
Autoimmunity
Impaired clearance of apoptotic cells can lead to autoantibody production and autoimmune diseases such as systemic lupus erythematosus. Defects in efferocytosis are a common feature in autoimmune conditions.
From inflammatory cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate neutrophil apoptosis? | CRISPR knockout in HL-60 or primary neutrophils |
| Does point mutation in CASP3 affect substrate cleavage? | Knock-in of catalytic dead mutant |
| Can overexpression of BCL2 delay inflammatory cell apoptosis? | Lentiviral overexpression in macrophages |
| How does tagging of CYCS affect its release? | Tagged knock-in with fluorescent protein |
| What is the role of MERTK in efferocytosis? | Knockout in macrophage cell line |
| Can CRISPR library screening identify novel apoptosis regulators? | Genome-wide KO library in inflammatory cells |
How to Study the inflammatory cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine exposure | Quantify apoptosis in KO models |
| Caspase activity assay | Caspase-3/7 activity | Validate apoptotic execution |
| Western blot | Cleaved caspase-3, PARP | Confirm apoptosis induction |
| Live-cell imaging | Mitochondrial permeabilization | Track apoptosis dynamics |
| Efferocytosis assay | Phagocytic uptake of apoptotic cells | Study clearance mechanisms |
| Metabolite profiling | Released metabolites from apoptotic cells | Identify tissue messengers |
| CRISPR library screening | Gene essentiality for apoptosis | Discover novel regulators |
| RNA-seq | Transcriptional changes during apoptosis | Identify pathways and biomarkers |
Flow Cytometry and Annexin V Staining
Flow cytometry with Annexin V and propidium iodide is a standard method to quantify apoptosis in inflammatory cells. This technique distinguishes early apoptotic, late apoptotic, and necrotic cells. It is widely used to assess the effect of genetic perturbations on cell death.
Western Blot and Caspase Activity Assays
Western blotting for cleaved caspases and PARP confirms apoptotic execution. Caspase activity assays using fluorogenic substrates measure enzymatic activity. These methods are essential for validating CRISPR knockout or knock-in models.
Live-Cell Imaging and Time-Lapse Microscopy
Live-cell imaging with fluorescent reporters (e.g., CYCS-GFP) allows real-time monitoring of apoptotic events. Time-lapse microscopy can track mitochondrial permeabilization and apoptotic body formation. This approach provides spatial and temporal resolution.
Efferocytosis Assays
Efferocytosis is measured by co-culturing labeled apoptotic cells with phagocytes and quantifying internalization. Flow cytometry or microscopy can assess phagocytic index. This method is critical for studying the clearance phase of inflammatory cell apoptosis.
How CRISPR Can Be Used to Study GO:0006925 inflammatory cell apoptotic process
Knockout
CRISPR knockout of genes such as CASP3, BAX, or MERTK in inflammatory cell lines (e.g., THP-1, HL-60) enables loss-of-function studies to determine their role in apoptosis and efferocytosis. Knockout models are essential for validating drug targets and understanding resistance mechanisms.
Point Mutation
Introducing point mutations (e.g., catalytic dead CASP3) via CRISPR knock-in allows precise dissection of enzymatic activity versus scaffolding functions. This approach is valuable for studying phosphorylation sites or cleavage-resistant mutants.
Knock-in
Tagged knock-in of genes like CYCS with fluorescent proteins enables real-time imaging of apoptotic events. Knock-in of reporter cassettes can also monitor promoter activity during inflammation.
Overexpression
CRISPR activation or lentiviral overexpression of anti-apoptotic genes (e.g., BCL2) can delay apoptosis in inflammatory cells, helping to study survival signaling. Overexpression of efferocytosis receptors (e.g., AXL) can enhance clearance.
How EDITGENE Supports inflammatory cell apoptotic process Research
Researchers studying inflammatory cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in apoptosis regulation, clearance, or inflammation resolution. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for inflammatory cell apoptotic process research.
Frequently Asked Questions About inflammatory cell apoptotic process
What is GO:0006925?
GO:0006925 is the Gene Ontology term for inflammatory cell apoptotic process, defined as any apoptotic process in an inflammatory cell such as a neutrophil or macrophage.
What genes are involved in inflammatory cell apoptotic process?
Key genes include CASP3, CASP8, BAX, BCL2, TP53, MERTK, and AXL, among others.
How is inflammatory cell apoptosis studied?
Common methods include flow cytometry with Annexin V, caspase activity assays, Western blot, live-cell imaging, and efferocytosis assays.
Why is efferocytosis important in inflammation?
Efferocytosis clears apoptotic inflammatory cells, preventing secondary necrosis and promoting resolution of inflammation.
What diseases are linked to defective inflammatory cell apoptosis?
Defective apoptosis or clearance is linked to inflammatory arthritis, autoimmunity, cancer, and chronic infections.
Can CRISPR be used to study inflammatory cell apoptosis?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in apoptosis pathways.
What metabolites are released from apoptotic cells?
Apoptotic cells release metabolites such as ATP and UTP that act as tissue messengers.
How does inflammation affect neutrophil apoptosis?
Inflammatory mediators can delay neutrophil apoptosis, prolonging their presence at inflammatory sites.
What is the role of caspase-3 in inflammatory cell apoptosis?
Caspase-3 is an executioner caspase that cleaves substrates to dismantle the cell during apoptosis.
What experimental models are used for inflammatory cell apoptosis research?
Models include knockout mice, CRISPR-edited cell lines (e.g., THP-1, HL-60), and primary macrophages.
Conclusion
Inflammatory cell apoptotic process (GO:0006925) is a fundamental biological process that controls the lifespan of inflammatory cells and is essential for resolving inflammation. Dysregulation of this process contributes to a range of diseases, from arthritis to cancer. Advances in CRISPR-based models and screening technologies are enabling precise dissection of the underlying mechanisms. EDITGENE provides the tools and expertise to accelerate research in this field, from knockout to library screening.
References
- 1. Doran AC et al.. 2020. Efferocytosis in health and disease.. Nat Rev Immunol 20(4):254-267 PMID: 31822793
- 2. Mehrotra P et al.. 2022. Drugging the efferocytosis process: concepts and opportunities.. Nat Rev Drug Discov 21(8):601-620 PMID: 35650427
- 3. Schilperoort M et al.. 2023. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation.. Immunol Rev 319(1):65-80 PMID: 37158427
- 4. Schneider K et al.. 2023. Apoptotic cell clearance components in inflammatory arthritis.. Immunol Rev 319(1):142-150 PMID: 37507355
- 5. Xu X et al.. 2019. Apoptosis and apoptotic body: disease message and therapeutic target potentials.. Biosci Rep 39(1) PMID: 30530866
- 6. Henson PM et al.. 2001. Apoptotic cell removal.. Curr Biol 11(19):R795-805 PMID: 11591341
- 7. Medina CB et al.. 2020. Metabolites released from apoptotic cells act as tissue messengers.. Nature 580(7801):130-135 PMID: 32238926
- 8. Kuo WT et al.. 2019. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.. Gastroenterology 157(5):1323-1337 PMID: 31401143
